. SDF-1 provokes an intracellular Ca 2+ response in the SU-DHL-4 DLBCL cell line involving intracellular Ca 2+ pool mobilization and Orai1/STIM1 extracellular Ca 2+ influx. Ca 2+ responses to SDF-1 (100 ng/mL) were measured using Fluo2-LR-AM Ca 2+ dye and recorded by video microscopy (Zeiss LSM 510) using ×25 objective. Black arrows indicate SDF-1 addition. Each trace represents the response of one cell and data are representative of at least 3 independent experiments. Typical response of unique cell (peak or peak follow by sustained plateau phase) are present as example (Ab). Data were processed using GraphPad prism. (A) Pharmacological characterization of SDF-1-induced Ca 2+ increase. Cells were recorded in extracellular saline solution (HBSS) containing 2 mM Ca 2+ (2 Ca, (Aa)) or in Ca 2+-free HBSS (0 Ca, (Ac)). Cells were pre-incubated with BTP2 (Ae) or GSK7975A (Af) at 10 µ M for 30 min and recorded in 2 mM Ca 2+ HBSS containing inhibitors. (Ad,Ag) Histograms represent areas under curves (AUC) calculated, under various recording conditions, between the application time of SDF-1 and t = 2050 s, and normalized compared to control (2 Ca or shNT). Data are expressed as mean ± SEM, * p < 0.05. (B) Effect of Orai1 or STIM1 expression knock-down on SDF-1-induced Ca 2+ response. The stable modified SU-DHL-4 cell line established after lentiviral transduction with plasmid containing non targeting shRNA (shNT), shRNA against Orai1 or STIM1 were recorded in extracellular saline solution (HBSS) containing 2 mM Ca 2+ .
. Validation of pharmacological and shRNA strategies used to study Ca 2+ signaling in SU-DHL-4 (left) and HLY1 (right) cell lines. Ca 2+ responses to TG (1 µ M) were recorded on cell population using a Hitachi F-2500 spectrofluorimeter. Cells were loaded with Indo1-AM in Ca 2+ -free HBSS, then at 500 s, 2mM Ca 2+ were added in the extracellular medium to visualize SOCE. Data were processed using GraphPad prism. The data represent the result of 3 independent experiments. Histograms represent areas under curves (AUC) calculated between the application of TG to 500 s for measuring intracellular pool released by TG and between the application of 2 mM Ca 2+ (at 500 s) and the end of recordings (at 1200 s) for measuring SOCE. Data are expressed as mean ± SEM, * p < 0.05. Ca 2+ responses to SDF-1 (100 ng/mL) were measured as described in Figure S1 . Cells were preincubated or not (2Ca) with AMD3100 (5 µ M) for 30 min and recorded in 2 mM Ca 2+ HBSS with or without inhibitor. Histograms represent areas under curves (AUC) calculated, under various recording conditions, between the application time of SDF-1 and t = 2000 s, and normalized compared to control (2 Ca). Data are expressed as mean±SEM, * p < 0.05. (B) SDF-1-induced SU-DHL-4 and HLY-1 migration is dependent on CXCR4 activation. Cell migration was assessed as described in Figure 2 . To test the effect of AMD3100 on chemotaxis induced by SDF-1, cells were pre-treated for 20 min with AMD3100 (150 nM) before loading onto upper transwell chambers maintained in medium during the experiment. Results are presented as migration index obtained by dividing the number of migrated cells in the studied condition by the number of migrated cells in the absence of chemoattractant (control). Histograms represent mean ± SEM from at least 3 independent experiments, * p < 0.05. (C) Total CXCR4 expression is not altered by knock-down of Orai1 or STIM1 in DLBCL cell lines. The stable modified SU-DHL-4 and HLY-1 cell lines established after lentiviral transduction with plasmid containing non-targeting shRNA (shNT), shRNA against Orai1 or STIM1 were harvested and lysed and the expression level of CXCR4 was evaluated by immunoblot analysis. β-actin was used as loading control. (D) Membrane CXCR4 expression is not altered by knock-down of Orai1 or STIM1 in DLBCL cell lines. SU-DHL-4 and HLY-1 cells expressing sh NT or sh Orai1 or sh STIM1 were stained with PE/Cy5 anti-human CXCR4 (dashed lines) or PE/Cy5 isotype control (lines). Fluorescence intensity was measured by flow cytometry.
